Recalls (Biologics)
Recalls are a firm's removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers and against which the agency would initiate legal action, e.g., seizure. Recalls may be conducted on a firm's own initiative, by FDA request, or by FDA order under statutory authority.
Market Withdrawals are a firm's removal or correction of a distributed product which involves a minor violation that would not be subject to legal action by the FDA, or which involves no violation.
Recalls older than 2 years are available on FDA Archive.
Class I Recalls by Year
- 2022 Biologics Recalls (Archived)
- 2021 Biologics Recalls (Archived)
CBER Recall Postings
- CBER FY 2019 Recall Postings (Archived)
- CBER FY 2018 Recall Postings (Archived)
Related Information
Paragraph Header
Contact Us
White Oak Campus
10903 New Hampshire Ave
Silver Spring, MD 20993
United States
For Latest Updates Follow
@FDADrugs
The latest information from the Center for Biologics Evaluation and Research.